MedTrace Logo

Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis

NCT02320500 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-04-06

No results posted yet for this study

Summary

Patients with chronic knee pain attributed to osteoarthritis and referred to orthopedics as potential candidates for a knee replacement will receive standard physiotherapy or myofascial-specific therapy over 8 weeks. Based on the investigators pilot investigation, the investigators expect those who receive myofascial-specific therapy to experience reduced pain (compared to the standard therapy group) and increased flexibility compared to baseline levels. This simple conservative therapy could postpone (or in some cases, eliminate) the need for a knee replacement since pain is the major indication for surgery. If successful, this treatment could improve the quality of life and increase productivity for thousands suffering from knee osteoarthritis and preserve valuable health care resources.

Conditions

  • Osteoarthritis, Knee

Interventions

BEHAVIORAL

Standard Physiotherapy

standard of care physiotherapy once every 2 weeks for 8 weeks

OTHER

Myofascial-specific therapy

Once every 2 weeks for 8 weeks (includes trigger point injections if deemed 'necessary' by chronic pain physician)

Sponsors & Collaborators

  • Queen's University

    lead OTHER

Principal Investigators

  • Richard Henry, MD, FRCPC · Queens University/Kingston General Hospital

  • Gavin Wood, MD, FRCSC · Queens University/Kingston General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-07-31
Completion
2016-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02320500 on ClinicalTrials.gov